Fund Holdings — GREAT POINT PARTNERS LLC

Total Portfolio Value:
$586.73M
Total Bought:
$155.48M
Total Sold:
$183.47M
Net Transaction:
-$27.99M
Notable People:
Ronald Marc Panzier
Securities
▲▼
SharesValue
Q3 2023
▲▼
Q4 2023
▲▼
Change
▲▼
Q3 2023
▲▼
Q4 2023
▲▼
Weight (%)
▲▼
Change
▲▼
Alpine Immune Sciences Inc3,078,6333,703,433+624,800$35.25M$70.59M12.03%+$35.34M
Cytokinetics, Incorporated(CYTK)600,000500,000-100,000$17.68M$41.74M7.11%+$24.07M
UroGen Pharma Ltd.(URGN)2,620,5452,620,5450$36.71M$39.31M6.70%+$2.59M
Pliant Therapeutics, Inc.(PLRX)1,755,1841,823,184+68,000$30.43M$33.02M5.63%+$2.58M
Ultragenyx Pharmaceutical Inc.(RARE)727,426648,000-79,426$25.93M$30.99M5.28%+$5.05M
Xenon Pharmaceuticals Inc.(XENE)500,001600,000+99,999$17.08M$27.64M4.71%+$10.56M
Rapt Therapeutics Inc1,458,0701,099,753-358,317$24.23M$27.33M4.66%+$3.10M
Alkermes plcSHS(ALKS)875,044875,0440$24.51M$24.27M4.14%-$236.3K
Aerovate Therapeutics Inc1,091,2331,037,690-53,543$14.81M$23.48M4.00%+$8.67M
Vaxcyte, Inc.(PCVX)531,211360,000-171,211$27.08M$22.61M3.85%-$4.47M
Evolus, Inc.(EOLS)2,186,9342,000,000-186,934$19.99M$21.06M3.59%+$1.07M
Anaptysbio Inc894,333976,981+82,648$16.06M$20.93M3.57%+$4.86M
Immunocore Holdings plcADS(IMCR)290,917293,000+2,083$15.10M$20.02M3.41%+$4.92M
Neurogene Inc.(NGNE)0994,229+994,229$0$19.27M3.28%+$19.27M
Amicus Therapeutics Inc
COM
857,0001,280,500+423,500$10.42M$18.17M3.10%+$7.75M
Tourmaline Bio Inc0672,885+672,885$0$17.62M3.00%+$17.62M
ABIVAX Société AnonymeADS(ABVX)01,550,000+1,550,000$0$16.59M2.83%+$16.59M
Zura Bio LimitedCL A(ZURA)3,295,0003,295,0000$21.75M$15.39M2.62%-$6.36M
Optinose Inc8,839,9398,839,9390$10.87M$11.40M1.94%+$530.4K
Apogee Therapeutics Inc400,000400,0000$8.52M$11.18M1.90%+$2.66M
Arvinas, Inc.(ARVN)0234,082+234,082$0$9.63M1.64%+$9.63M
Karuna Therapeutics Inc60,50030,250-30,250$10.23M$9.57M1.63%-$655.5K
Vistagen Therapeutics, Inc.(VTGN)01,858,735+1,858,735$0$9.55M1.63%+$9.55M
Terns Pharmaceuticals Inc645,8991,309,975+664,076$3.25M$8.50M1.45%+$5.25M
Intra-Cellular Therapies Inc225,000110,607-114,393$11.72M$7.92M1.35%-$3.80M
Sarepta Therapeutics, Inc.(SRPT)165,20080,000-85,200$20.03M$7.71M1.31%-$12.31M
Insmed Incorporated(INSM)394,872225,912-168,960$9.97M$7.00M1.19%-$2.97M
Puma Biotechnology, Inc.(PBYI)01,093,273+1,093,273$0$4.73M0.81%+$4.73M
Ocular Therapeutix, Inc.(OCUL)0700,000+700,000$0$3.12M0.53%+$3.12M
Spyre Therapeutics, Inc.(SYRE)0125,000+125,000$0$2.69M0.46%+$2.69M
Arcellx Inc
COMMON STOCK
287,50048,264-239,236$10.32M$2.68M0.46%-$7.64M
Merus N V020,000+20,000$0$550.0K0.09%+$550.0K
Axsome Therapeutics, Inc.(AXSM)04,963+4,963$0$395.0K0.07%+$395.0K
Mural Oncology Pub Ltd Co011,509+11,509$0$68.1K0.01%+$68.1K
ACLARIS THERAPEUTICS INCCOM(ACRS)1,691,7680-1,691,768$11.59M$0—-$11.59M
ACUMEN PHARMACEUTICALS INCCOM(ABOS)1,074,1010-1,074,101$4.46M$0—-$4.46M
AKERO THERAPEUTICS INCCOM198,5000-198,500$10.04M$0—-$10.04M
CEREVEL THERAPEUTICS HLDNG ICOM215,0000-215,000$4.69M$0—-$4.69M
GENERATION BIO COCOM1,022,5370-1,022,537$3.88M$0—-$3.88M
GOSSAMER BIO INCCOM(GOSS)6,230,2720-6,230,272$5.19M$0—-$5.19M
GRACELL BIOTECHNOLOGIES INCSPONSORED ADS579,6670-579,667$1.67M$0—-$1.67M
HERON THERAPEUTICS INCCOM(HRTX)4,737,3680-4,737,368$4.88M$0—-$4.88M
IGM BIOSCIENCES INCCOM615,3170-615,317$5.14M$0—-$5.14M
MIRATI THERAPEUTICS INCCOM86,3020-86,302$3.76M$0—-$3.76M
POINT BIOPHARMA GLOBAL INCCOM2,909,9600-2,909,960$19.41M$0—-$19.41M
PTC THERAPEUTICS INCCOM(PTCT)500,0000-500,000$11.21M$0—-$11.21M
RENEO PHARMACEUTICALS INCCOM1,167,0610-1,167,061$8.89M$0—-$8.89M
REPLIMUNE GROUP INCCOM(REPL)638,4950-638,495$10.92M$0—-$10.92M
SOLID BIOSCIENCES INCCOM NEW450,4030-450,403$1.14M$0—-$1.14M
TALARIS THERAPEUTICS INCCOM1,000,0000-1,000,000$2.81M$0—-$2.81M
Page 1 of 1
GREAT POINT PARTNERS LLC — 13F Holdings — Q4 2023 | TickerTrail